背景:在结直肠手术中广泛采用了微创手术技术。新的技术突破导致了更少的侵入性替代方案,如单端口手术,但是这受到了技术挑战的阻碍,例如在有限的空间内机械臂的碰撞。直观的达芬奇单端口机器人平台是一个新颖的系统,克服了这些挑战。
■本研究旨在评估IntuitivedaVinci单端口机器人平台在成年患者右节段结肠切除术中的安全性和可行性。这些发现可能会为更广泛地使用单端口机器人手术奠定基础。
■直观的达芬奇单端口机器人是专为单端口机器人手术而设计的系统。该平台使用单个C形臂实现灵活的端口位置和有效的内部和外部运动范围。在本研究中,在2022年5月至2022年11月期间,使用该平台对成年患者进行了右结肠切除术,并将其与在2019年1月至2022年12月期间使用标准多端口平台进行的成年患者的右结肠切除术进行了比较.主要结局指标是安全性和质量事件发生率。
结果:在30名患者中,16.7%的患者(n=5)接受了单口机器人右结肠切除术,83.3%(n=25)接受了多口右结肠切除术。在单端口组中,40%的患者(n=2)发生了安全性/质量事件(术后门静脉血栓形成和术后过度疼痛)。在多端口组中,32%的患者(n=8)发生1次安全/质量事件,8%(n=2)发生1次以上事件。
结论:这项初步研究,第一个食品和药物管理局批准的,研究者在结直肠手术中使用这个平台,表明该平台是正确的结肠切除术的安全可行的选择。初步评估,在相关安全/质量事件方面,它似乎与多端口平台相当。
背景:Clinicaltrials.govNCT05321134。
BACKGROUND: Minimally invasive surgical techniques have been widely adopted in colorectal surgery. New technological breakthroughs have led to even less invasive alternatives like single-port surgery, but this has been hindered by technical challenges such as the collision of robotic arms within a limited space. The Intuitive da Vinci Single-Port robotic platform is a novel system that overcomes some of these challenges.
UNASSIGNED: This study aimed to assess the safety and feasibility of the Intuitive da Vinci Single-Port robotic platform in right segmental colectomies among adult patients. These findings may set the stage for more widespread use of single-port robotic surgery.
UNASSIGNED: The Intuitive da Vinci Single-Port robot is a system designed specifically for single-port robotic surgery. This platform enables flexible port location and efficient internal and external range of motion using a single C-shaped arm. In the present study, right colectomies were performed in adult patients using this platform between May 2022 and November 2022, and they were compared to right colectomies in adult patients performed using the standard multiport platform between January 2019 and December 2022. The main outcome measure was safety and quality event rates.
RESULTS: Of 30 patients, 16.7% of patients (n = 5) underwent single-port robotic right colectomy and 83.3% (n = 25) underwent multiport right colectomy. In the single-port group, 40% of patients (n = 2) developed a safety/quality event (postoperative portal vein thrombosis and excessive postoperative pain). In the multiport group, 32% of patients (n = 8) developed 1 safety/quality event and 8% (n = 2) had more than 1 event.
CONCLUSIONS: This preliminary study, one of the first Food and Drug Administration-approved, investigator-initiated uses of this platform in colorectal surgeries, shows that this platform is a safe and feasible option for right colectomies. On preliminary evaluation, it appears comparable in terms of relevant safety/quality events to the multiport platform.
BACKGROUND: Clinicaltrials.gov NCT05321134.